TABLE 1.

Study population

PatientSexaAge (yr)Early time pointLate time point
ALT level (U/liter)HBV-PCRViral load (GE/ml) * 105bWeek after clinical onsetALT level (U/liter)HBV-PCRWeek after clinical onsetDominant epitope
p1f183,262+0.151<5017pol-455
p2f622,971+6.651<5010pol-455
p3m272,604+159.621<5010env-335
p4m294,197+3.941<5012pol-455
p5f292,855+2.581<5014env-335
p6m244,286+>1,0001<5015core-18
  • a f, female; m, male.

  • b GE, genome equivalents.